- Austria / Österreich
- Bosnia and Herzegovina / Босна и Херцеговина
- Bulgaria / България
- Croatia / Hrvatska
- Czech Republic & Slovakia / Česká republika & Slovensko
- France / France
- Germany / Deutschland
- Greece / ΕΛΛΑΔΑ
- Italy / Italia
- Netherlands / Nederland
- Nordic / Nordic
- Poland / Polska
- Portugal / Portugal
- Romania & Moldova / România & Moldova
- Slovenia / Slovenija
- Serbia & Montenegro / Србија и Црна Гора
- Spain / España
- Switzerland / Schweiz
- Turkey / Türkiye
- UK & Ireland / UK & Ireland
CANBERRA, Australia: A senate committee report recommending the passage of legislation that changes the way the Therapeutic Goods Administration (TGA) regulates medicines and medical devices has been welcomed by the Australian Dental Industry Association (ADIA). It delivers a long-standing legislative reform that ADIA has been lobbying politicians of all political persuasions to deliver on for nearly a decade.
“This bill contains important reforms that will cut the red tape associated with introducing into the Australian market new and innovative patient treatment and diagnostic options,” said ADIA CEO Troy Williams.
The bill will reportedly also make changes that support amendments to the Therapeutic Goods Act 1989 made in 2017. The reforms will allow the TGA to authorise Australian companies to undertake conformity assessments, a significant departure from past practice where only the TGA could perform such evaluations.
“This legislation, combined with the legislative changes made last year that ADIA also secured, creates a far more efficient system for dental product manufacturers to introduce new products to the Australian market. Whereas previously the TGA was the sole source of authority, the increasing use of overseas regulators and third-party Australian conformity assessment bodies will provide alternatives without compromising patient safety,” said Williams.
Williams went on to say that ADIA has been pushing for the changes because they create a regulatory framework for dental products that is based on a risk management approach designed to ensure public health and safety. He added that the reforms will simultaneously free the dental industry from any unnecessary regulatory burden.
Tags:
Fri. 26 April 2024
12:00 pm EST (New York)
How you can access data-driven decision making
Mon. 29 April 2024
12:30 pm EST (New York)
Root caries: The challenge in today’s cariology
Tue. 30 April 2024
1:00 pm EST (New York)
Neodent Discovery: Neoarch Guided Surgery—from simple to complex cases
Fri. 3 May 2024
1:00 pm EST (New York)
Osseointegration in extrēmus: Complex maxillofacial reconstruction & rehabilitation praeteritum, praesens et futurum
Tue. 7 May 2024
8:00 pm EST (New York)
You got this! Diagnosis and management of common oral lesions
Thu. 9 May 2024
8:00 pm EST (New York)
Empowering your restorative practice: A comprehensive guide to clear aligner integration and success
Mon. 13 May 2024
9:00 am EST (New York)
To post a reply please login or register